Aniracetam
From Wikipedia, the free encyclopedia
 |
|
|
Aniracetam
|
|
| Systematic (IUPAC) name | |
| 1-(4-methoxyphenyl)pyrrolidin-2-one | |
| Identifiers | |
| CAS number | |
| ATC code | N06 |
| PubChem | |
| Chemical data | |
| Formula | C12H13NO3 |
| Mol. mass | 219.237 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Unscheduled (US) |
| Routes | Oral |
Aniracetam (Draganon®, Sarpul®) is a nootropic drug of the racetam family. It is lipid soluble and has possible cognition enhancing effects. It has been tested in animals extensively, and in Alzheimer's patients, but has not been tested in healthy, unimpaired humans.
[edit] See also
[edit] External links
- Nootropics - Reviewing The Smart-Drugs, By James South, MA
- The Cognitive Enhancement Research Institute
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
